FZMD · Fuse Medical, Inc.
Market Cap
$2.22M
Shares
73.90M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Mark W. Brooks | President | $821,000 |
| Christopher C. Reeg | Chief Executive Officer | $354,655 |
| Lawrence S. Yellin | Chief Financial Officer | $250,000 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Mark W. Brooks | President | $1,441,370 |
| Christopher C. Reeg | Chief Executive Officer | $564,297 |
| Lawrence S. Yellin | Chief Financial Officer | $200,000 |
| William E. McLaughlin III | Chief Financial Officer | $199,500 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Mark W. Brooks | President | $1,872,662 |
| Christopher C. Reeg | Chief Executive Officer | $499,341 |
| William E. McLaughlin III | Chief Financial Officer | $176,153 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Mark W. Brooks | President | $1,314,887 |
| Christopher C. Reeg | Chief Executive Officer | $302,085 |
| William E. McLaughlin III | Chief Financial Officer | $200,000 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Mark W. Brooks | President | $1,435,000 |
| Christopher C. Reeg | Chief Executive Officer | $453,050 |
| William E. McLaughlin III | Chief Financial Officer | $300,000 |